Literature DB >> 28123864

Diagnostic performance of an automated analysis software for the diagnosis of Alzheimer's dementia with 18F FDG PET.

Sasan Partovi1, Roger Yuh1, Sara Pirozzi2, Ziang Lu1, Spencer Couturier1, Ulrich Grosse1, Mark D Schluchter3, Aaron Nelson2, Robert Jones1, James K O'Donnell1, Peter Faulhaber1.   

Abstract

The objective of this study was to assess the ability of a quantitative software-aided approach to improve the diagnostic accuracy of 18F FDG PET for Alzheimer's dementia over visual analysis alone. Twenty normal subjects (M:F-12:8; mean age 80.6 years) and twenty mild AD subjects (M:F-12:8; mean age 70.6 years) with 18F FDG PET scans were obtained from the ADNI database. Three blinded readers interpreted these PET images first using a visual qualitative approach and then using a quantitative software-aided approach. Images were classified on two five-point scales based on normal/abnormal (1-definitely normal; 5-definitely abnormal) and presence of AD (1-definitely not AD; 5-definitely AD). Diagnostic sensitivity, specificity, and accuracy for both approaches were compared based on the aforementioned scales. The sensitivity, specificity, and accuracy for the normal vs. abnormal readings of all readers combined were higher when comparing the software-aided vs. visual approach (sensitivity 0.93 vs. 0.83 P = 0.0466; specificity 0.85 vs. 0.60 P = 0.0005; accuracy 0.89 vs. 0.72 P<0.0001). The specificity and accuracy for absence vs. presence of AD of all readers combined were higher when comparing the software-aided vs. visual approach (specificity 0.90 vs. 0.70 P = 0.0008; accuracy 0.81 vs. 0.72 P = 0.0356). Sensitivities of the software-aided and visual approaches did not differ significantly (0.72 vs. 0.73 P = 0.74). The quantitative software-aided approach appears to improve the performance of 18F FDG PET for the diagnosis of mild AD. It may be helpful for experienced 18F FDG PET readers analyzing challenging cases.

Entities:  

Keywords:  Alzheimer’s dementia; PET; quantitative; software aided

Year:  2017        PMID: 28123864      PMCID: PMC5259585     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  47 in total

1.  Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

Authors:  K Herholz; E Salmon; D Perani; J C Baron; V Holthoff; L Frölich; P Schönknecht; K Ito; R Mielke; E Kalbe; G Zündorf; X Delbeuck; O Pelati; D Anchisi; F Fazio; N Kerrouche; B Desgranges; F Eustache; B Beuthien-Baumann; C Menzel; J Schröder; T Kato; Y Arahata; M Henze; W D Heiss
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

2.  Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project.

Authors:  Silvia Morbelli; Andrea Brugnolo; Irene Bossert; Ambra Buschiazzo; Giovanni B Frisoni; Samantha Galluzzi; Bart N M van Berckel; Rik Ossenkoppele; Robert Perneczky; Alexander Drzezga; Mira Didic; Eric Guedj; Gianmario Sambuceti; Gianluca Bottoni; Dario Arnaldi; Agnese Picco; Fabrizio De Carli; Marco Pagani; Flavio Nobili
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Clifford R Jack; Marilyn S Albert; David S Knopman; Guy M McKhann; Reisa A Sperling; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 4.  Alzheimer's disease: neuropathologic findings and recent advances in imaging.

Authors:  Joseph F Norfray; James M Provenzale
Journal:  AJR Am J Roentgenol       Date:  2004-01       Impact factor: 3.959

5.  Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.

Authors:  Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

6.  Frontal lobe hypometabolism and depression in Alzheimer's disease.

Authors:  N Hirono; E Mori; K Ishii; Y Ikejiri; T Imamura; T Shimomura; M Hashimoto; H Yamashita; M Sasaki
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

7.  Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections.

Authors:  J H Burdette; S Minoshima; T Vander Borght; D D Tran; D E Kuhl
Journal:  Radiology       Date:  1996-03       Impact factor: 11.105

8.  FDG PET imaging in patients with pathologically verified dementia.

Authors:  J M Hoffman; K A Welsh-Bohmer; M Hanson; B Crain; C Hulette; N Earl; R E Coleman
Journal:  J Nucl Med       Date:  2000-11       Impact factor: 10.057

9.  Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.

Authors:  Atsushi K Kono; Kazunari Ishii; Keitaro Sofue; Naokazu Miyamoto; Setsu Sakamoto; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-22       Impact factor: 9.236

10.  Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in an oncology patient population.

Authors:  Sharif Kershah; Sasan Partovi; Bryan J Traughber; Raymond F Muzic; Mark D Schluchter; James K O'Donnell; Peter Faulhaber
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

View more
  3 in total

1.  Image reconstruction methods affect software-aided assessment of pathologies of [18F]flutemetamol and [18F]FDG brain-PET examinations in patients with neurodegenerative diseases.

Authors:  Elin Lindström; Jenny Oddstig; Torsten Danfors; Jonas Jögi; Oskar Hansson; Mark Lubberink
Journal:  Neuroimage Clin       Date:  2020-08-19       Impact factor: 4.881

2.  Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders.

Authors:  Daniela D Maltais; Lennon G Jordan; Hoon-Ki Min; Toji Miyagawa; Scott A Przybelski; Timothy G Lesnick; Robert R Reichard; Dennis W Dickson; Melissa E Murray; Kejal Kantarci; Bradley F Boeve; Val J Lowe
Journal:  J Nucl Med       Date:  2020-03-20       Impact factor: 11.082

3.  Machine learning identified an Alzheimer's disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson's disease dementia.

Authors:  Audrey Katako; Paul Shelton; Andrew L Goertzen; Daniel Levin; Bohdan Bybel; Maram Aljuaid; Hyun Jin Yoon; Do Young Kang; Seok Min Kim; Chong Sik Lee; Ji Hyun Ko
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.